A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy
Titel:
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy
Auteur:
Hurvitz, Sara A. Dalenc, Florence Campone, Mario O’Regan, Ruth M. Tjan-Heijnen, Vivianne C. Gligorov, Joseph Llombart, Antonio Jhangiani, Haresh Mirshahidi, Hamid R. Tan-Chiu, Elizabeth Miao, Sara El-Hashimy, Mona Lincy, Jeremie Taran, Tetiana Soria, Jean-Charles Sahmoud, Tarek André, Fabrice